These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10960167)
21. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Glynn LM; Davis EP; Sandman CA Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135 [TBL] [Abstract][Full Text] [Related]
22. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Gold PW; Licinio J; Wong ML; Chrousos GP Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444 [TBL] [Abstract][Full Text] [Related]
23. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596 [TBL] [Abstract][Full Text] [Related]
24. Crowding stress impairs the pituitary-adrenocortical responsiveness to the vasopressin but not corticotropin-releasing hormone stimulation. Bugajski J; Borycz J; Glod R; Bugajski AJ Brain Res; 1995 May; 681(1-2):223-8. PubMed ID: 7552286 [TBL] [Abstract][Full Text] [Related]
25. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Mlynarik M; Zelena D; Bagdy G; Makara GB; Jezova D Horm Behav; 2007 Mar; 51(3):395-405. PubMed ID: 17258216 [TBL] [Abstract][Full Text] [Related]
26. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors. Herman JP; Dolgas CM; Carlson SL Neuroscience; 1998 Sep; 86(2):449-59. PubMed ID: 9881860 [TBL] [Abstract][Full Text] [Related]
27. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311 [TBL] [Abstract][Full Text] [Related]
29. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243 [TBL] [Abstract][Full Text] [Related]
30. Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. Dinan TG; Scott LV J Anat; 2005 Sep; 207(3):259-64. PubMed ID: 16185250 [TBL] [Abstract][Full Text] [Related]
31. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536 [TBL] [Abstract][Full Text] [Related]
32. Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation. Goekoop JG; de Winter RP; de Rijk R; Zwinderman KH; Frankhuijzen-Sierevogel A; Wiegant VM Psychiatry Res; 2006 Feb; 141(2):201-11. PubMed ID: 16436301 [TBL] [Abstract][Full Text] [Related]
33. The central mechanism of hypothalamic-pituitary-adrenocortical system hyperfunction in depressed patients. Jiang HK; Wang JY; Lin JC Psychiatry Clin Neurosci; 2000 Apr; 54(2):227-34. PubMed ID: 10803820 [TBL] [Abstract][Full Text] [Related]
34. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients. Watson S; Gallagher P; Smith MS; Young AH; Ferrier IN Psychoneuroendocrinology; 2007 Jun; 32(5):464-9. PubMed ID: 17442500 [TBL] [Abstract][Full Text] [Related]
35. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633 [TBL] [Abstract][Full Text] [Related]
36. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179 [TBL] [Abstract][Full Text] [Related]
37. Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia and after unilateral electroconvulsive therapy. Dored G; Stefansson S; d'Elia G; Kågedal B; Karlberg E; Ekman R Acta Psychiatr Scand; 1990 Sep; 82(3):204-9. PubMed ID: 2174200 [TBL] [Abstract][Full Text] [Related]
38. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. Lizcano F; Salvador J Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442 [TBL] [Abstract][Full Text] [Related]
39. The hypothalamic-pituitary-adrenocortical axis in major depression. Stokes PE; Sikes CR Endocrinol Metab Clin North Am; 1988 Mar; 17(1):1-19. PubMed ID: 2837389 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine. Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]